Acquisition of restor3d Cervical and Lumbar Implant Systems
We are excited to announce the acquisition of restor3d’s cervical and lumbar cages, along with two additional 510(k)-cleared devices, bringing Pressio’s portfolio to a total of three FDA-cleared products. This acquisition was finalized on December 31, 2024. restor3d’s flagship product features its proprietary TIDAL Technology™, supported by dozens of peer-reviewed publications in leading biomaterials journals. These studies highlight its superior bone ingrowth and ongrowth capabilities, leading to improved clinical outcomes.
These advanced implants are manufactured using cutting-edge 3D printing technology and incorporate TIDAL Technology™, ensuring exceptional design and performance. This strategic acquisition, secured on highly favorable terms, allows immediate revenue generation starting January 1, 2025. It enhances our market presence and aligns seamlessly with Pressio’s strategic initiatives. The restor3d team will actively support the transition process, ensuring smooth integration and continuity.
Notably, this acquisition strengthens our ability to drive the adoption of the CONTINUUM staple system among new surgeon design team members and new surgeon users, further underscoring our commitment to delivering innovative spine care solutions. With this acquisition, Pressio becomes the only company in the world to offer a single-use, sterile-pack kit that includes cervical interbody cages and fixation options. Moreover, thanks to our acquisition of nitinol plating technology last year, Pressio remains unmatched as the only company providing nitinol-based fixation solutions, offering staples and plates.